Multimorbidity and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies.

IF 4.3 Q2 BUSINESS
Yaguan Zhou, Yating You, Yuting Zhang, Yue Zhang, Changzheng Yuan, Xiaolin Xu
{"title":"Multimorbidity and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies.","authors":"Yaguan Zhou, Yating You, Yuting Zhang, Yue Zhang, Changzheng Yuan, Xiaolin Xu","doi":"10.1016/j.tjpad.2025.100164","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic diseases (e.g., hypertension, diabetes, and heart diseases) have been proposed as marked predictors of incident dementia. However, synthesised evidence on the effect of multimorbidity on dementia is still lacking. We aim to summarise the association between multimorbidity and risk of dementia in longitudinal cohorts.</p><p><strong>Methods: </strong>In this systematic review and meta-analysis, we conducted a systematic search in PubMed, Web of Science and Embase from inception to Dec 14, 2024, to identify longitudinal cohort studies reporting the association between multimorbidity or multimorbidity patterns and risk of dementia. Information of included studies were extracted by three reviewers (YaZ, YY and YuZ), and the quality assessment was conducted using the Newcastle-Ottawa Scale. The inverse-variance weighted random effects meta-analysis was performed to obtain the pooled hazard ratios (HRs) and 95 % confidence intervals (CIs) for dementia associated with multimorbidity and cardiometabolic multimorbidity (CMM). Cochran's Q test and the I<sup>2</sup> statistic were used to indicate heterogeneity among the studies. Meta-regression analysis, subgroup analysis and sensitivity analysis were conducted to determine any valid sources of heterogeneity. This study was registered with PROSPERO (CRD42023403684).</p><p><strong>Results: </strong>We included 17 longitudinal cohort studies (2262,885 middle-aged and older participants) in the systematic review, of which seven were included in meta-analysis. All studies presented moderate to high methodological quality. Meta-analysis showed a positive association between multimorbidity and incident dementia (HR=1.53, 95 % CI=1.12 to 2.09), with substantial heterogeneity (I<sup>2</sup>=95.2 %). Studies using health records to measure dementia tend to find a stronger positive relationship between multimorbidity and risk of dementia than those using self-report (HR<sub>health records</sub>=1.94, 95 % CI=1.35 to 2.78, I<sup>2</sup>=94 %; HR<sub>self-report</sub>=1.17, 95 % CI=1.07 to 1.28, I<sup>2</sup>=0 %). The impacts of CMM were also observed, and the HRs for dementia ranged from 2.49 (combination of heart diseases and stroke: 95 % CI=1.64 to 3.78) to 3.77 (combination of diabetes, heart diseases and stroke: 95 % CI=2.02 to 7.02). The heterogeneity was moderate, with I<sup>2</sup> ranging from 46.9 % (p for heterogeneity=0.152) to 84.1 % (p for heterogeneity=0.002). The impacts of number of diseases, multimorbidity clusters, and multimorbidity trajectory on risk of dementia were narratively summarised due to lacking comparable studies. Limited evidence (only one study) precluded quantitative synthesis for the association of physical and psychological multimorbidity with dementia.</p><p><strong>Conclusion: </strong>Multimorbidity and CMM pattern were significantly associated with risk of dementia, while the effect of physical and psychological multimorbidity remain inconclusive. Individuals affected by multimorbidity should be prioritised in risk factor modification and dementia prevention. Preventing the development of multimorbidity is also crucial-particularly those who already have one chronic disease-in order to maintain cognitive health.</p>","PeriodicalId":22711,"journal":{"name":"The Journal of Prevention of Alzheimer's Disease","volume":" ","pages":"100164"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Prevention of Alzheimer's Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.tjpad.2025.100164","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BUSINESS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic diseases (e.g., hypertension, diabetes, and heart diseases) have been proposed as marked predictors of incident dementia. However, synthesised evidence on the effect of multimorbidity on dementia is still lacking. We aim to summarise the association between multimorbidity and risk of dementia in longitudinal cohorts.

Methods: In this systematic review and meta-analysis, we conducted a systematic search in PubMed, Web of Science and Embase from inception to Dec 14, 2024, to identify longitudinal cohort studies reporting the association between multimorbidity or multimorbidity patterns and risk of dementia. Information of included studies were extracted by three reviewers (YaZ, YY and YuZ), and the quality assessment was conducted using the Newcastle-Ottawa Scale. The inverse-variance weighted random effects meta-analysis was performed to obtain the pooled hazard ratios (HRs) and 95 % confidence intervals (CIs) for dementia associated with multimorbidity and cardiometabolic multimorbidity (CMM). Cochran's Q test and the I2 statistic were used to indicate heterogeneity among the studies. Meta-regression analysis, subgroup analysis and sensitivity analysis were conducted to determine any valid sources of heterogeneity. This study was registered with PROSPERO (CRD42023403684).

Results: We included 17 longitudinal cohort studies (2262,885 middle-aged and older participants) in the systematic review, of which seven were included in meta-analysis. All studies presented moderate to high methodological quality. Meta-analysis showed a positive association between multimorbidity and incident dementia (HR=1.53, 95 % CI=1.12 to 2.09), with substantial heterogeneity (I2=95.2 %). Studies using health records to measure dementia tend to find a stronger positive relationship between multimorbidity and risk of dementia than those using self-report (HRhealth records=1.94, 95 % CI=1.35 to 2.78, I2=94 %; HRself-report=1.17, 95 % CI=1.07 to 1.28, I2=0 %). The impacts of CMM were also observed, and the HRs for dementia ranged from 2.49 (combination of heart diseases and stroke: 95 % CI=1.64 to 3.78) to 3.77 (combination of diabetes, heart diseases and stroke: 95 % CI=2.02 to 7.02). The heterogeneity was moderate, with I2 ranging from 46.9 % (p for heterogeneity=0.152) to 84.1 % (p for heterogeneity=0.002). The impacts of number of diseases, multimorbidity clusters, and multimorbidity trajectory on risk of dementia were narratively summarised due to lacking comparable studies. Limited evidence (only one study) precluded quantitative synthesis for the association of physical and psychological multimorbidity with dementia.

Conclusion: Multimorbidity and CMM pattern were significantly associated with risk of dementia, while the effect of physical and psychological multimorbidity remain inconclusive. Individuals affected by multimorbidity should be prioritised in risk factor modification and dementia prevention. Preventing the development of multimorbidity is also crucial-particularly those who already have one chronic disease-in order to maintain cognitive health.

痴呆的多发病和风险:纵向队列研究的系统回顾和荟萃分析。
背景:慢性疾病(如高血压、糖尿病和心脏病)已被认为是痴呆发生的显著预测因素。然而,关于多重发病对痴呆的影响的综合证据仍然缺乏。我们的目的是总结纵向队列中多病与痴呆风险之间的关系。方法:在这一系统回顾和荟萃分析中,我们对PubMed、Web of Science和Embase进行了系统检索,从开始到2024年12月14日,以确定报告多发病或多发病模式与痴呆风险之间关联的纵向队列研究。纳入研究的信息由三位审稿人(YaZ、YY和YuZ)提取,并采用Newcastle-Ottawa量表进行质量评价。进行反方差加权随机效应荟萃分析,以获得痴呆合并多病和心血管代谢多病(CMM)的合并风险比(hr)和95%置信区间(ci)。采用Cochran’s Q检验和I2统计量来显示研究间的异质性。进行meta回归分析、亚组分析和敏感性分析以确定是否存在有效的异质性来源。本研究已在PROSPERO注册(CRD42023403684)。结果:我们在系统评价中纳入了17项纵向队列研究(2262,885名中老年受试者),其中7项纳入meta分析。所有研究的方法学质量均为中等至高。荟萃分析显示,多发病与痴呆发生率呈正相关(HR=1.53, 95% CI=1.12 ~ 2.09),存在显著异质性(I2= 95.2%)。使用健康记录测量痴呆的研究往往发现,与使用自我报告的研究相比,多病与痴呆风险之间存在更强的正相关(HRhealth records=1.94, 95% CI=1.35至2.78,I2= 94%;HRself-report=1.17, 95% CI=1.07 ~ 1.28, I2= 0%)。还观察了CMM的影响,痴呆症的hr范围从2.49(心脏病和中风合并:95% CI=1.64至3.78)到3.77(糖尿病、心脏病和中风合并:95% CI=2.02至7.02)。异质性为中等,I2范围为46.9% (p =0.152)至84.1% (p =0.002)。由于缺乏可比研究,对疾病数量、多发病群和多发病轨迹对痴呆风险的影响进行了叙述性总结。有限的证据(只有一项研究)排除了对身体和心理多病与痴呆的关联的定量综合。结论:多病和CMM模式与痴呆风险有显著相关性,而生理和心理多病对痴呆风险的影响尚无定论。受多重发病影响的个体应优先考虑危险因素调整和痴呆预防。为了保持认知健康,预防多种疾病的发展也至关重要——尤其是那些已经患有一种慢性病的人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
The Journal of Prevention of Alzheimer's Disease
The Journal of Prevention of Alzheimer's Disease Medicine-Psychiatry and Mental Health
CiteScore
9.20
自引率
0.00%
发文量
0
期刊介绍: The JPAD Journal of Prevention of Alzheimer’Disease will publish reviews, original research articles and short reports to improve our knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.JPAD will publish also the meeting abstracts from Clinical Trial on Alzheimer Disease (CTAD) and will be distributed both in paper and online version worldwide.We hope that JPAD with your contribution will play a role in the development of Alzheimer prevention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信